Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

CytoCore Inc. (MDIT) had Revenue of $6.81M for the most recently reported fiscal year, ending 2017-12-31.

Quarterly Annual

Figures for fiscal year ending 2017-12-31

Income Statement Financials
Revenue	$6.81M
Net Income	$-6.90M
Cost of Goods Sold	$6.65M
Gross Profit	$0.16M
Operating Expenses	$13.29M
Operating Income	$-6.48M
Non-Operating Income/Expense	$-0.82M
Pre-Tax Income	$-7.30M
Normalized Pre-Tax Income	$-7.30M
Income after Taxes	$-6.81M
Income from Continuous Operations	$-6.81M
Consolidated Net Income/Loss	$-6.81M
Normalized Income after Taxes	$-6.81M
EBIT	$-6.48M
EBITDA	$-6.00M
Weighted-Average Shares Outstanding (Basic)	26.44M
Weighted-Average Shares Outstanding (Diluted)	26.44M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$3.46M
Property, Plant, and Equipment	$1.78M
Long-Term Assets	$12.49M
Total Assets	$15.96M
Current Liabilities	$3.78M
Long-Term Debt	$4.91M
Long-Term Liabilities	$6.40M
Total Liabilities	$10.18M
Common Equity	$4.81M
Tangible Shareholders Equity	$-0.12M
Shareholders Equity	$5.78M
Common Shares Outstanding	28.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-3.57M
Cash Flow from Investing Activities	$-0.13M
Cash Flow from Financial Activities	$3.46M
Beginning Cash	$0.11M
End Cash	$0.07M
Increase/Decrease in Cash	$-0.04M
Stock-Based Compensation	$0.46M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.46
Debt to Equity Ratio	0.92
Gross Margin	2.38%
Operating Margin	-95.11%
EBIT Margin	-95.11%
EBITDA Margin	-88.04%
Pre-Tax Profit Margin	-107.12%
Profit Margin	-101.31%
Free Cash Flow	$-3.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.43
Inventory Turnover	2.77
Receiveable Turnover	15.04
Days Sales in Receivables	24.27
Return on Equity	-141.51%
Return on Tangible Equity	5537.44%
Return on Assets	-42.69%
Return on Investments	-63.72%
Book Value Per Share	$0.20
Free Cash Flow per Share	$-0.14
Operating Cash Flow per Share	$-0.14

Data from Zacks Investment Research, Inc.